E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/21/2006 in the Prospect News Biotech Daily.

Jefferies keeps Advanced Magnetics at buy

Advanced Magnetics, Inc. was kept at a buy rating and $42 price target by Jefferies & Co., Inc. analyst Adam Walsh following the company's reported third-quarter loss per share of $0.57, 10 cents below the analyst's estimate and 5 cents below Street consensus. Advanced Magnetics' cash and cash equivalents totaled $48 million at June 30, which should be sufficient to launch ferumoxytol, according to the analyst. Shares of the Cambridge, Mass.-based pharmaceutical products company were down 57 cents, or 1.76%, at $31.75 on volume of 52,724 shares versus the three-month running average of 2,989,800 shares. (Nasdaq: CGPI)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.